Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 0
No TA breakdown available.
R&D Momentum
73/100
Pipeline Velocity
55/100
Trial Completion Rate
100/100
Pipeline Concentration
100/100
Pipeline Freshness
81/100
Activity
Last 14 days
From Acute Response to Chronic Adaptation: Immunological Effects of an Eight-Week CrossFit Training Program in Sedentary Adults
The Effect of a Midwife-Led Digital Follow-Up Program on Postpartum Depression, Perceived Social Support, and Breastfeeding Self-Efficacy in Women After Cesarean Section: A Randomized Controlled Trial
he Effect of MBSR (Conscious Awareness-Based Stress Reduction) Program on Anxiety, Work-Related Emotional Burnout and Job Satisfaction in Midwives
Effects of Varied Post-Activation Potentiation Protocols on Countermovement Jump Performance in Muay Thai Athletes: A Comparative Study Between Ramadan and Post-Ramadan Periods
Improving Palatal Donor Site Healing and Reducing Postoperative Morbidity With Concentrated Growth Factor and Collagen Fleece: Randomized Controlled Clinical Study
The Effect of Cross Training on Clinical and Functional Outcomes in Frozen Shoulder Rehabilitation
Evaluation of Preoperative and Postoperative Anxiety in Living Liver Donors
Effect of Adherence to a Gluten-Free Diet on Cognitive and Motor Dual-Task Performance in Adolescents Diagnosed With Celiac Disease
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)